The result of a dispute of the Federal Antimonopoly service (FAS) in Russia pharmacy has gone the drug Biperiden, which is vital for people with schizophrenia and Parkinson’s disease. Psychiatrists appealed to the head of the Ministry of health Veronika Skvortsova with a request to cancel the decision of the FAS.
According to RBC, the Federal Antimonopoly service has cancelled the registration rates of Biperidene – without such registration, the drug in Russia can not be sold. In most FAS the decision of cancellation of registration of prices explained that previously the service was registered by the high price of medicine.
In Russia, pertaining to vital medicines Biperiden is sold under four brands. Of them are only suitable for injection Biperiden was known to Russian consumers as medicine “Akineton”. He disappeared in Russia after a dispute arose about the price of the drug, and was deregistered.
Biperiden is included in the list of vital and essential drugs (EDL). It is used to combat the side effects in the treatment of schizophrenia to relieve tension of the muscles, paralyzing patients. In a letter to Veronika Skvortsova, which was signed by more than forty people, the doctors asked to cancel the decision of the FAS. Psychiatrists point to the fact that biperiden injection is needed in the aggravation of the side effects and the threats to life requiring immediate assistance. “Akineton”, who disappeared in Russia, effective when patients cannot or refuse to drink the medicine in pill form. He is also the only allowed for children.
In the FAS said that sales in the Russian market, the manufacturer had to reduce the price of essential medicine several times. But the company has reduced the price of the drug only slightly. As a result, in October 2018, she was given a warning, then the anti-monopolists and not revoked the registration prices.
Earlier Magicforum wrote about the recall of pharmacies blood pressure medicine on the basis of Carcinogenicity valsartan.